A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA)

NCT03223376 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

703

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Gastric Cancer

Interventions

COMBINATION_PRODUCT: fruquintinib +paclitaxel
COMBINATION_PRODUCT: fruquintinib placebo + paclitaxel

Sponsor

Hutchison Medipharma Limited

Collaborators

[object Object]